Identification of Gene Signatures Associated with Ulcerative Colitis and the Association with Immune Infiltrates in Colon Cancer

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Feb 6

PMID 36742294

Authors

Zhaoji Pan

Hao Lin

Yanyan Fu

Fanpeng Zeng

Feng Gu

Guoping Niu

Jian Fang

Bing Gu

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory bowel diseases, including ulcerative colitis (UC) and Crohn's disease, are some of the most common inflammatory disorders of the gastrointestinal tract. The dysfunction of the immune system in the intestines is suggested to be the underlying cause of the pathogenesis of UC. However, the mechanisms regulating these dysfunctional immune cells and inflammatory phenotypes are still unclear.

Methods: The differential expression analysis on microarray datasets were performed including GSE24287, GSE87466, GSE102133, and GSE107499, including 376 samples. "Gene Ontology" and "Kyoto Encyclopedia of Genes and Genomes" pathway enrichment analyses were conducted to identify the common differentially expressed genes (DEGs) in these datasets and explore their underlying biological mechanisms. Further algorithms like "Cell-type Identification by Estimating Relative Subsets of RNA Transcripts" were used to determine the infiltration status of immune cells in patients with UC. "Cytoscape" and "Gene Set Enrichment Analysis" were used to screen for hub genes and to investigate their biological mechanisms. The Tumor Immune Estimation Resource database was used to study the correlation between hub genes and infiltrating immune cells in patients with UC. A total of three hub genes, CCL3, MMP3, and TIMP1, were identified using Cytoscape.

Results: A positive correlation was observed between these hub genes and patients with active UC. These genes served as a biomarker for active UC. Moreover, a decrease in CCL3, MMP3, and TIMP1 expression was observed in the mucosa of the intestine of patients with active UC who responded to Golimumab therapy. In addition, results show a significant positive correlation between CCL3, MMP3, and TIMP1 expression and different immune cell types including dendritic cells, macrophages, CD8+ T cells, and neutrophils in patients with colon cancer. Moreover, CCL3, MMP3, and TIMP1 expression were strongly correlated with different immune cell markers.

Conclusion: Study results show the involvement of hub genes like CCL3, MMP3, and TIMP1 in the pathogenesis of UC. These genes could serve as a novel pharmacological regulator of UC. These could be used as a therapeutic target for treating patients with UC and may serve as biomarkers for immune cell infiltration in colon cancer.

Citing Articles

Establishment of a nomogram model based on immune-related genes using machine learning for aortic dissection diagnosis and immunomodulation assessment.

Hou Y, Zhao Y, Shi Z, Pan Y, Shi K, Zhao C Int J Med Sci. 2025; 22(4):873-886.

PMID: 39991758 PMC: 11843136. DOI: 10.7150/ijms.100572.

Integrated skin metabolomics and network pharmacology to explore the mechanisms of Goupi Plaster for treating knee osteoarthritis.

Liu J, Li Y, Wang J, Guan B, Chen Z, Liu Z J Tradit Complement Med. 2025; 14(6):675-686.

PMID: 39850603 PMC: 11752118. DOI: 10.1016/j.jtcme.2024.04.004.

UDP-glucuronosyltransferases 2A3 as a biomarker for ulcerative colitis and colon cancer.

Chen H Front Genet. 2024; 15:1419755.

PMID: 39717480 PMC: 11663933. DOI: 10.3389/fgene.2024.1419755.

Comparison of volumetric brain analysis in subjects with rheumatoid arthritis and ulcerative colitis.

Cox J, De Groot M, Kempton M, Williams S, Cole J Front Med (Lausanne). 2024; 11:1468910.

PMID: 39635596 PMC: 11614619. DOI: 10.3389/fmed.2024.1468910.

Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins.

Du F, Li J, Zhong X, Zhang Z, Zhao Y Heliyon. 2024; 10(21):e40118.

PMID: 39568849 PMC: 11577214. DOI: 10.1016/j.heliyon.2024.e40118.

References

Banks C, Bateman A, Payne R, Johnson P, Sheron N . Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol. 2002; 199(1):28-35. DOI: 10.1002/path.1245. View

von Lampe B, Barthel B, Coupland S, Riecken E, Rosewicz S . Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut. 2000; 47(1):63-73. PMC: 1727961. DOI: 10.1136/gut.47.1.63. View

Zhao X, Fan J, Zhi F, Li A, Li C, Berger A . Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. Hum Mol Genet. 2015; 24(16):4615-24. DOI: 10.1093/hmg/ddv192. View

Chen Z, Sun Y, Wang Q, Ma H, Ma Z, Yang C . Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis. Front Genet. 2021; 12:697514. PMC: 8299473. DOI: 10.3389/fgene.2021.697514. View

Nie Q, Cheng Y, Xie Y, Zhou Y, Bai X, Cao Y . Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance. World J Gastroenterol. 2002; 8(2):282-7. PMC: 4658367. DOI: 10.3748/wjg.v8.i2.282. View

Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T . Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021; 56(6):489-526. PMC: 8137635. DOI: 10.1007/s00535-021-01784-1. View

Sherry B, Gallegos C, Bauer D, Davatelis G, Wolpe S, Masiarz F . Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med. 1988; 168(6):2251-9. PMC: 2189160. DOI: 10.1084/jem.168.6.2251. View

Fang J, Wang H, Fang X, Li N, Hu H, Bian M . Low STYK1 expression indicates poor prognosis in gastric cancer. Cancer Manag Res. 2018; 10:6669-6676. PMC: 6289209. DOI: 10.2147/CMAR.S181910. View

Kobayashi T, Siegmund B, Le Berre C, Wei S, Ferrante M, Shen B . Ulcerative colitis. Nat Rev Dis Primers. 2020; 6(1):74. DOI: 10.1038/s41572-020-0205-x. View

10.

Zhang T, Song B, Zhu W, Xu X, Gong Q, Morando C . An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies. PLoS One. 2012; 7(5):e37139. PMC: 3351422. DOI: 10.1371/journal.pone.0037139. View

11.

Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D . Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity. World J Gastroenterol. 2003; 9(12):2843-5. PMC: 4612067. DOI: 10.3748/wjg.v9.i12.2843. View

12.

Lakatos G, Hritz I, Varga M, Juhasz M, Miheller P, Cierny G . The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis. 2012; 30(3):289-95. DOI: 10.1159/000336995. View

13.

Kapsoritakis A, Kapsoritaki A, Davidi I, Lotis V, Manolakis A, Mylonis P . Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol. 2008; 8:55. PMC: 2613880. DOI: 10.1186/1471-230X-8-55. View

14.

Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M . Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126(2):451-9. DOI: 10.1053/j.gastro.2003.11.010. View

15.

Li C, Ai G, Wang Y, Lu Q, Luo C, Tan L . Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway. Pharmacol Res. 2019; 152:104603. DOI: 10.1016/j.phrs.2019.104603. View

16.

Ntanasis-Stathopoulos I, Fotiou D, Terpos E . CCL3 Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2020; 1231:13-21. DOI: 10.1007/978-3-030-36667-4_2. View

17.

Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P . Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2024; 1(3):e36. PMC: 10989974. DOI: 10.1002/imt2.36. View

18.

Schaller T, Batich K, Suryadevara C, Desai R, Sampson J . Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Rev Clin Immunol. 2017; 13(11):1049-1060. PMC: 6020048. DOI: 10.1080/1744666X.2017.1384313. View

19.

Li K, Strauss R, Ouahed J, Chan D, Telesco S, Shouval D . Molecular Comparison of Adult and Pediatric Ulcerative Colitis Indicates Broad Similarity of Molecular Pathways in Disease Tissue. J Pediatr Gastroenterol Nutr. 2018; 67(1):45-52. DOI: 10.1097/MPG.0000000000001898. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View